Related Experiment Videos
Multiple spinal meningiomas after tamoxifen therapy: a case report
G B Colazza1, G Di Gennaro, P P Quarato
1IRCCS Neuromed, Via Atinense 18, I-86077 Pozzilli (IS), Italy.
Summary
This case study suggests tamoxifen treatment may increase the risk of developing multiple spinal meningiomas. Long-term neurological surveillance is recommended for patients treated with tamoxifen to monitor for secondary tumors.
Area of Science:
- Neuro-oncology
- Endocrinology
Background:
- Tamoxifen is a selective estrogen receptor modulator used in breast cancer treatment.
- Multiple spinal meningiomas are rare tumors, and their etiology is not fully understood.
Observation:
- A 74-year-old woman presented with progressive spastic paraparesis.
- She had a history of breast cancer treated with mastectomy and subsequent four-year tamoxifen therapy.
- MRI revealed three distinct spinal meningiomas.
Findings:
- The presence of multiple spinal meningiomas in this patient is highly unusual.
- Tamoxifen's known tumor-inducing properties raise suspicion for its role in meningioma development.
Implications:
- This case suggests a potential link between tamoxifen use and the development of spinal meningiomatosis.
- Long-term clinical and neurological monitoring is advised for patients receiving tamoxifen to detect secondary neoplasms.